Lentiviral vectors are advanced gene delivery tools widely used for stable gene transfer applications in virotherapy and gene therapy. They have the ability to efficiently deliver genes into… Read More

North America Hemoglobinopathies Market Outlook The North America Hemoglobinopathies market size is anticipated to grow at a CAGR of 5.10% during the forecast period of 2024-2032, driven by… Read More

Transfection is the process of deliberately introducing nucleic acids into cells. It has become a fundamental tool for cell and molecular biology research as it allows for the study of genes… Read More

IntroductionDid you know that approximately 100,000 people in the U.S. suffer from sickle cell disease (SCD)? This genetic disorder primarily affects African Americans and Hispanic America… Read More

Genezen, a leading cell and gene therapy Contract Development and Manufacturing Organization (CDMO), today announced licensing of the Cytegrity proprietary ­­­­stable product… Read More

[Research Report] Transfection reagents and equipment market is expected to grow from US$ 1,170.79 million in 2022 to US$ 2,145.03 million by 2030; it is anticipated to record a CAGR of 7.8%… Read More

Lentiviral Vectors MarketLentiviral vectors are experimental gene therapy treatments used to deliver healthy genes into a patient's cells and tissues to treat disease. They have emerged as a… Read More

It has been just revealed the fact that the first CRISPR gene-editing therapy has been approved in the US. Check out the latest reports about this below. Gene-editing therapy in the US The U… Read More

Viral Vector Market was worth USD 0.60 billion in 2022 and is estimated to grow at a CAGR of 19.7% in the forecasted period. The forecasted revenue hints at a growth of around 2.13 bill… Read More

Base Pair Biotechnologies, "The Aptamer Discovery Company™" has been recently awarded a grant from NIH entitled, "Aptamer engineering of lentiviral vectors for cardiac gene therapies"… Read More

The emergence of RNA synthesis in vitro and in vivo delivery methods has garnered significant attention in the biomedical field, particularly regarding the applications of synthetic mRN… Read More

The US and Europe gene editing market size is expected to reach US$ 15,052.92 million in 2030 from US$ 3,955.09 million in 2022; the market is estimated to record a CAGR of 18.2% during 2023… Read More

Introduction:The viral vector manufacturing market is witnessing remarkable growth due to the increasing demand for gene therapy and vaccine development. According to a recent report by Mark… Read More

The medical industry expects viral vectors to grow in prominence in transferring genetic material into the genetic composition of cells. Adeno-associated Viruses (AAVs) have become sought-af… Read More

The Lentiviral Vectors Market is slated to grow at a gracious rate of 11.4% by the year 2032. With value-oriented approach being the need of the hour, the healthcare… Read More

The latest research study “Viral Vector Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the … Read More

Viral vectors play a vital role in the development of cell and gene therapies (C&GTs). By delivering genetic material to patients’ cells to replace dysfunctional or damaged DNA, th… Read More

Thalassemia market was valued at USD 2.48 billion by 2023, growing with 9.7% CAGR during the forecast period, 2023-2033.Thalassemia is an inherited or genetic blood disorder… Read More

The global market for viral vector manufacturing recorded a historic CAGR of 12.8% in the last 9 years from 2012 to 2021. In 2022, global revenue from viral vector manufa… Read More

Thalassemia market was valued at USD 2.48 billion by 2022, growing with 9.7% CAGR during the forecast period, 2022-2031.Thalassemia is an inherited or genetic blood disorder… Read More

DecisionDatabases added the latest report with a global perspective on the Lentiviral Vectors Market studied under different segments, including type, application, and regions. The report is… Read More

Judicial Watch announced today that it received 2369 pages of records from the National Institutes of Health (NIH) revealing over two dozen cases where research involving recombina… Read More

DUBLIN, Aug. 12, 2021 /PRNewswire/ -- The "Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market by Scale of Operation, Type of Vector, Application Area, Therapeutic Area… Read More

Viral Vector Manufacturing Market Research Report: by Type (Retroviral Vectors, Adenoviral Vectors and others), by Disease (Genetic Disorders, Infectious Diseases, and others), by Applicatio… Read More

According to the new market research report “Gene Therapy Market by Vectors [Non-viral (Oligonucleotides), Viral (Retroviral (Gammaretroviral, Lentiviral), Adeno-associated]… Read More

Researchers increased the production of lentiviral vectors by host cells by co-expressing the proteins SPSB1 or Tax. Mechanistically, this was shown to have a range of effects, including inc… Read More

J Cell Sci 2003, 116:2471�C2481.PubMedCrossRef Seventy four. Kim JW, Lemke Grams: Hedgehog-regulated localization involving Vax2 settings vision improvement. Genes Dev '… Read More

Parkinson’s Disease research has come a long way since its first medical descriptions over 200 years ago. The most effective Parkinson’s treatment is Levodopa (L-dopa), an amino… Read More

Criterios diagnósticos para la infección por el virus de la inmunodeficiencia felina y el virus de la leucemia felina en gatos domésticos de Buenos Aires. VENTURINI, MAR… Read More

GOODBYE CHEMOTHERAPYThe race to cure cancer using our own immune systemChemotherapy is a barbaric therapy - its like killing a wasp biting a human with a machine gun. To kill the 3% of rogue… Read More